Brighthouse Financial, Inc.
No enriched coverage for $BHF in the last 7 days.
No SEC Form 4 filings for $BHF in the last 30 days.
See all $BHF insider activity →Keefe, Bruyette & Woods kept a Market Perform rating on Brighthouse Finl with a $55 price target, implying a 15.1% upside from the Oct 14 close of $47.80. The target reflects market conditions, investor sentiment, and sensitivity to earnings estimates, according to the analyst note.
JPMorgan upgraded Brighthouse Financial (BHF) to Neutral, lowering its price target to $55.00. The stock is down 26% YTD, trading at $47.80. Analyst Pablo Singzon cited high-risk liabilities and limited capital flexibility. The Aquarian deal's deadline has been extended to December 2026, with potential termination fees of $226M and $143M. Talcott/Sixth Street may bid for BHF at $52 per share.
BASF proposed a takeover of Evonik, reflecting defensive consolidation in Europe's chemical sector. Other notable deals include Aquarian's bid for Brighthouse Financial with a 31.4% spread, Thoma Bravo's offer for Accelerant Holdings, and Merck's potential acquisition of Bio-Techne. Bullish's $4.2B deal for Equiniti highlights tokenization trends. Spreads vary, signaling different risk profiles.
Recent BHF coverage spans financial news, mergers & acquisitions and earnings.
Analyst upgrade maintains rating with a higher price target, suggesting modest upside potential.
The downgrade and lower target suggest downside pressure on BHF.
Large spread indicates market doubt about deal completion.
The renewed acquisition attempt could pressure BHF stock lower if the deal faces regulatory hurdles.
Significant miss drives sharp price drop.
AlphAI scores every news story that mentions BHF with an AI model for sentiment and relevance, and aggregates insider trades from Brighthouse Financial, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Keefe, Bruyette & Woods kept a Market Perform rating on Brighthouse Finl with a $55 price target, implying a 15.1% upside from the Oct 14 close of $47.80. The target reflects market conditions, investor sentiment, and sensitivity to earnings estimates, according to the analyst note.
1 min readJPMorgan upgraded Brighthouse Financial (BHF) to Neutral, lowering its price target to $55.00. The stock is down 26% YTD, trading at $47.80. Analyst Pablo Singzon cited high-risk liabilities and limited capital flexibility. The Aquarian deal's deadline has been extended to December 2026, with potential termination fees of $226M and $143M. Talcott/Sixth Street may bid for BHF at $52 per share.
2 min readBASF proposed a takeover of Evonik, reflecting defensive consolidation in Europe's chemical sector. Other notable deals include Aquarian's bid for Brighthouse Financial with a 31.4% spread, Thoma Bravo's offer for Accelerant Holdings, and Merck's potential acquisition of Bio-Techne. Bullish's $4.2B deal for Equiniti highlights tokenization trends. Spreads vary, signaling different risk profiles.
3 min readSixth Street, through Talcott Financial Group, has renewed its bid to acquire Brighthouse Financial Inc. while the company's current sale agreement with Aquarian Holdings is under regulatory review. Brighthouse, Sixth Street, and Talcott declined to comment. The deal's progress is uncertain due to regulatory scrutiny.
2 min readCNO Financial Group (CNO) fell 5.1% post-earnings, trading at $49.44. Brighthouse Financial (BHF) reported $2.10B revenue, down 2.4% YoY, missing estimates, and dropped 15.3% to $52.42. Aflac (AFL) reported $4.22B revenue, down 6.9% YoY, in line with expectations, and fell 9.4% to $114.77. The market has shifted focus from AI to geopolitics and back to fundamentals.
3 min readBrighthouse Financial, Inc. (BHF) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On August 17, 2026, the Board of Directors of Brighthouse Financial, Inc. (“Brighthouse Financial” or the “Company”) appoi
2 min readA financial results roundup covers multiple insurers. HCI Group reported Q2 gross premiums earned of $321m and a 22.2% gross loss ratio, plus a completed $80m share buyback. Kingstone posted $15.5m net income and a 70.2% GAAP combined ratio. Kemper took a $460m goodwill impairment. Safety agreed to be acquired by Mapfre for about $1.54b at $105/share.
9 min readBrighthouse Financial, Inc. (BHF) filed an SEC Form 8-K — Results of Operations and Financial Condition. PUBLIC RELATIONS Brighthouse Financial, Inc. 11225 N. Community House Rd. Charlotte, NC 28277 Exhibit 99.1 FOR IMMEDIATE RELEASE Brighthouse Financial Announces Second Quarter 2026 Results • Estimated combined risk-based capital ("RBC") ratio between 430% and 450%; holding compan
6 min readA Burke & Herbert Financial Services insider sold shares for tax purposes tied to an option exercise, not an open-market sale. The chair and CEO David Boyle said the LINKBANCORP merger closed May 1. Burke & Herbert reported Q1 net income of $27.1M, 4.09% net interest margin, and $5.4B loans vs $6.3B deposits.
5 min readThis article provides a technical analysis and price forecast for Brighthouse Financial, Inc. Depositary Shares 6.75% Non-Cum Pfd Series B (BHFAO). It indicates a "Neutral" overall technical sentiment based on aggregating various technical signals, including momentum indicators like RSI and MACD. The analysis also highlights that BHFAO is trading below its 60-day and 200-day moving averages, while several simple moving averages (5-day, 10-day, 20-day, 60-day, 200-day, 250-day) suggest a "Buy" signal given its current share price of $15.98.
3 min read
